107 related articles for article (PubMed ID: 11480547)
1. 5-substituted 3,4-dihydro-3-amino-2H-1-benzopyran derivatives: synthesis and interaction with serotoninergic receptors.
Rezaie R; Joseph B; Bremner JB; Delagrange P; Kopp C; Misslin R; Pfeiffer B; Renard P; Guillaumet G
J Pharm Pharmacol; 2001 Jul; 53(7):959-68. PubMed ID: 11480547
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
Podona T; Guardiola-Lemaître B; Caignard DH; Adam G; Pfeiffer B; Renard P; Guillaumet G
J Med Chem; 1994 Jun; 37(12):1779-93. PubMed ID: 7912735
[TBL] [Abstract][Full Text] [Related]
3. 3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
Comoy C; Marot C; Podona T; Baudin ML; Morin-Allory L; Guillaumet G; Pfeiffer B; Caignard DH; Renard P; Rettori MC; Adam G; Guardiola-Lemaitre B
J Med Chem; 1996 Oct; 39(21):4285-98. PubMed ID: 8863806
[TBL] [Abstract][Full Text] [Related]
4. Substituted 3-amino and/or 3-aminomethyl-3,4-dihydro-2H-1-benzopyrans: synthesis and biological activity.
Comoy C; Guérin V; Pfeiffer B; Rettori MC; Renard P; Guillaumet G
Bioorg Med Chem; 2000 Mar; 8(3):483-95. PubMed ID: 10732964
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
[TBL] [Abstract][Full Text] [Related]
6. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N-(4-aryl-1-piperazinylbutyl)-substituted 7,8-benzo-1,3-diazaspiro[4,5]decane-2,4-dione derivatives with potential anxiolytic activity.
Kossakowski J; Zawadowski T; Turło J; Kleps J
Farmaco; 1998 Feb; 53(2):169-71. PubMed ID: 9604324
[TBL] [Abstract][Full Text] [Related]
8. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide.
Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E
Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A
J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm.
Metzenauer P; Barnes NM; Costall B; Gozlan H; Hamon M; Kelly ME; Murphy DA; Naylor RJ
Neuroreport; 1992 Jun; 3(6):527-9. PubMed ID: 1356500
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of N,N'-bis-aminoalkyl-substituted derivatives of bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide with potential anxiolytic activity.
Turło J; Zawadowski T
Farmaco; 1996 Dec; 51(12):815-8. PubMed ID: 9050215
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
Rënyi L; Evenden JL; Fowler CJ; Jerning E; Kelder D; Lake-Bakaar D; Larsson LG; Mohell N; Sällemark M; Ross SB
J Pharmacol Exp Ther; 2001 Dec; 299(3):883-93. PubMed ID: 11714872
[TBL] [Abstract][Full Text] [Related]
15. Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines.
Prunier H; Rault S; Lancelot JC; Robba M; Renard P; Delagrange P; Pfeiffer B; Caignard DH; Misslin R; Guardiola-Lemaitre B; Hamon M
J Med Chem; 1997 Jun; 40(12):1808-19. PubMed ID: 9191957
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity.
Kossakowski J; Zawadowski T; Kuśmierczyk J
Acta Pol Pharm; 1998; 55(4):315-8. PubMed ID: 9821397
[TBL] [Abstract][Full Text] [Related]
17. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
18. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.
Moltzen EK; Perregaard J; Meier E
J Med Chem; 1995 May; 38(11):2009-17. PubMed ID: 7783132
[TBL] [Abstract][Full Text] [Related]
19. [New serotonergic ligands with a benzopyran or dioxinopyridine structure: synthesis and activity].
Guillaumet G
J Pharm Belg; 1994; 49(3):216-20. PubMed ID: 7914534
[No Abstract] [Full Text] [Related]
20. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
Jerning E; Svantesson GT; Mohell N
Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
